Live Breaking News & Updates on Outsourding Pharma

Stay updated with breaking news from Outsourding pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Extensive £30 million ($38 million) study into liver cirrhosis

A £30 million ($38 million) study into liver cirrhosis, the most extensive ever conducted worldwide has been announced by Newcastle University and University of Edinburgh, funded by Boehringer Ingelheim. ....

City Of , United Kingdom , Quentin Anstee , Lykke Hinsch Gylvin , Outsourding Pharma , Neil Henderson , Newcastle University , University Of Edinburgh , Boehringer Ingelheim , Hinsch Gylvin , Newcastle Hospitals , Edinburgh Innovations , Markets Amp Regulations , Emerging Markets , Cell Amp Gene Therapies , Liver Disease , Clinical Trials ,

Extensive £30 million ($38 million) study into liver cirrhosis

A £30 million ($38 million) study into liver cirrhosis, the most extensive ever conducted worldwide has been announced by Newcastle University and University of Edinburgh, funded by Boehringer Ingelheim. ....

City Of , United Kingdom , Lykke Hinsch Gylvin , Quentin Anstee , Neil Henderson , Outsourding Pharma , University Of Edinburgh , Newcastle University , Boehringer Ingelheim , Hinsch Gylvin , Newcastle Hospitals , Edinburgh Innovations , Clinical Evolution , Preclinical Research , Clinical Development , Atient Centricity , Liver Disease , Clinical Trials ,